Schrodinger, Inc. (NASDAQ:SDGR – Get Free Report) CEO Ramy Farid sold 3,661 shares of the company’s stock in a transaction dated Thursday, March 5th. The stock was sold at an average price of $12.91, for a total transaction of $47,263.51. Following the completion of the sale, the chief executive officer owned 330,824 shares in the company, valued at approximately $4,270,937.84. This trade represents a 1.09% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink.
Schrodinger Stock Performance
Shares of NASDAQ SDGR opened at $12.74 on Friday. The company has a 50 day simple moving average of $14.77 and a two-hundred day simple moving average of $17.58. Schrodinger, Inc. has a fifty-two week low of $11.11 and a fifty-two week high of $27.63. The company has a market capitalization of $938.56 million, a price-to-earnings ratio of -8.97 and a beta of 1.57.
Schrodinger (NASDAQ:SDGR – Get Free Report) last issued its quarterly earnings results on Wednesday, February 25th. The company reported $0.44 EPS for the quarter, topping analysts’ consensus estimates of ($0.13) by $0.57. The firm had revenue of $87.24 million for the quarter, compared to analysts’ expectations of $83.66 million. Schrodinger had a negative return on equity of 29.47% and a negative net margin of 40.37%.The business’s revenue for the quarter was up 4.7% compared to the same quarter last year. During the same period in the previous year, the firm posted ($0.24) EPS. On average, analysts forecast that Schrodinger, Inc. will post -2.37 earnings per share for the current fiscal year.
Key Headlines Impacting Schrodinger
- Positive Sentiment: Yahoo Finance piece highlights an evolving investment thesis as Schrödinger shifts toward hosted software and resets targets, which could support longer-term sentiment if adoption and ARR trajectory improve. How The Schrödinger (SDGR) Investment Story Is Evolving With Hosted Software And Reset Targets
- Neutral Sentiment: Transcript from Schrödinger’s TD Cowen conference presentation provides management commentary and detail that investors can use to re-assess guidance, product roadmap and commercialization progress; useful but not an immediate catalyst. Schrödinger, Inc. (SDGR) Presents at TD Cowen 46th Annual Health Care Conference Transcript
- Negative Sentiment: CEO Ramy Farid sold 3,661 shares at an average $12.91 (?1.09% reduction in his stake), a high-profile insider sale that can signal near-term selling pressure. CEO Form 4
- Negative Sentiment: CFO Rachit Jain sold 1,631 shares at ~$12.90 (?3.01% reduction), adding to the cluster of exec sales that market participants often interpret as a negative signal. CFO Form 4
- Negative Sentiment: Other senior leaders (EVPs Kenneth Lorton and Yvonne Tran, CAO Jenny Herman, and insiders Robert Abel, Karen Akinsanya) executed small-to-moderate sales (roughly 600–1,366 shares each around $12.80–$12.91), collectively reducing insider holdings and contributing to downward pressure. Sample Insider Filing (Robert Abel)
- Negative Sentiment: Multiple filings show these sales occurred within a short window (Mar 4–6), which magnifies market reaction compared with isolated, scheduled sales; however, each sale is a small percentage of total insider stakes and could reflect diversification or option/vesting activity rather than a change in corporate outlook. SEC Filings
Wall Street Analyst Weigh In
A number of equities research analysts have recently commented on SDGR shares. KeyCorp cut their target price on Schrodinger from $28.00 to $25.00 and set an “overweight” rating on the stock in a research note on Thursday, January 8th. Bank of America upgraded shares of Schrodinger from a “neutral” rating to a “buy” rating and set a $24.00 price target on the stock in a research note on Monday, December 15th. TD Cowen reissued a “buy” rating on shares of Schrodinger in a research report on Thursday, January 8th. UBS Group assumed coverage on shares of Schrodinger in a research note on Wednesday, January 7th. They set a “neutral” rating and a $18.00 price objective for the company. Finally, Weiss Ratings reiterated a “sell (e+)” rating on shares of Schrodinger in a research note on Friday, January 9th. Four equities research analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, Schrodinger presently has a consensus rating of “Hold” and a consensus price target of $21.75.
Get Our Latest Stock Analysis on SDGR
Institutional Inflows and Outflows
A number of hedge funds and other institutional investors have recently modified their holdings of SDGR. EverSource Wealth Advisors LLC boosted its position in shares of Schrodinger by 722.8% during the fourth quarter. EverSource Wealth Advisors LLC now owns 1,374 shares of the company’s stock valued at $25,000 after buying an additional 1,207 shares during the last quarter. Los Angeles Capital Management LLC purchased a new position in Schrodinger in the 4th quarter worth about $26,000. Hantz Financial Services Inc. raised its position in Schrodinger by 5,025.8% in the 4th quarter. Hantz Financial Services Inc. now owns 1,589 shares of the company’s stock worth $28,000 after buying an additional 1,558 shares during the last quarter. State of Wyoming bought a new position in Schrodinger during the 2nd quarter valued at about $39,000. Finally, Aster Capital Management DIFC Ltd lifted its stake in Schrodinger by 212.4% during the 3rd quarter. Aster Capital Management DIFC Ltd now owns 1,943 shares of the company’s stock valued at $39,000 after acquiring an additional 1,321 shares during the period. 79.05% of the stock is owned by institutional investors.
Schrodinger Company Profile
Schrödinger, Inc is a life sciences and materials discovery company that specializes in the application of physics-based computational platforms to accelerate drug discovery and advanced materials design. Founded in 1990 by Professor Richard A. Friesner, Schrödinger has developed a suite of proprietary software tools—such as Maestro for molecular modeling, Glide for molecular docking and Jaguar for quantum chemistry calculations—that enable scientists to predict molecular behavior with high accuracy.
Featured Articles
- Five stocks we like better than Schrodinger
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
- Trump Planning to Use Public Law 63-43: Prepare Now
- How JPMorgan’s $8,000 Gold Call Will Leave Most Retirement Accounts Behind
- Silver Is the New Oil—And the World’s Running Dry
- Nvidia CEO Issues Bold Tesla Call
Receive News & Ratings for Schrodinger Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Schrodinger and related companies with MarketBeat.com's FREE daily email newsletter.
